quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:07·1716d
SECFiling
Chiasma, Inc. logo

SEC Form EFFECT filed by Chiasma, Inc.

CHMA· Chiasma, Inc.
Health Care
Original source

Companies

  • CHMA
    Chiasma, Inc.
    Health Care

Related

  • PR1268d
    Amryt Reports Q3 2022 Financial and Operational Results
  • PR1359d
    Amryt Reports Record Q2 2022 Results
  • PR1382d
    SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer
  • PR1451d
    Amryt Reports Record Q1 2022 Results
  • PR1507d
    Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
  • SEC1716d
    SEC Form 15-12B filed by Chiasma, Inc.
  • INSIDER1718d
    SEC Form 4: STONEPINE CAPITAL, L.P. returned 6,770,000 units of Common Stock to the company
  • 13D/G1718d
    SEC Form SC 13G/A filed by Chiasma, Inc. (Amendment)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022